The pharmaceutical company Sanofi want a
found a new company, the future active pharmaceutical ingredient
manufacture and market them to third parties. The shared
French corporation in Paris on Monday. The headquarters of the
Daughter is said to be in France.
In the new company, Sanofis will be trading and
Development activities with a total of six of the European ones
Locations bundled. Sanofi is also pulling an IPO
Society is considered, but will not be until 2022
decided, it said. The company should have one by then
Make annual sales of around one billion euros and thus in the
Industry rank second worldwide./knd/jkr/he
ISIN FR0000120578
AXC0230 2020-02-24 / 16: 54
Copyright dpa-AFX Wirtschaftsnachrichten GmbH. All rights reserved. Redistribution, republication or permanent storage without the express prior consent of dpa-AFX is not permitted.
– ,
